17 September 2026
Starter-dose GLP-1s still cut weight, far less than full strength
Low-dose tirzepatide averaged 5.5% body-weight loss over a year; low-dose semaglutide 2.2%.
The full briefing is in the app.
17 September 2026
Low-dose tirzepatide averaged 5.5% body-weight loss over a year; low-dose semaglutide 2.2%.
The full briefing is in the app.